Device / Technology News

RSS

MedicAlert Foundation's 'Code of Conduct' helps evaluate integrity of emergency medical information

The non-profit MedicAlert Foundation published a "Code of Conduct" in an effort to help consumers evaluate the integrity of organizations providing emergency medical information and identification services. In addition, as part of the "Code of Conduct" the Foundation has established business practice standards for medical information and identification service organizations that house consumer health information. Across the country millions of consumers are using personal health records, emergency medical information services, personal medical alarms systems or medical identification jewelry services.

16 Dec 2010

Miracor granted CE-Mark for PICSO Impulse System to improve ACS revascularization following PCI

Miracor Medical Systems GmbH announced today that the company has received CE-mark for the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System, designed to improve acute coronary syndrome (ACS) revascularization following primary percutaneous coronary intervention (PCI).

16 Dec 2010

International Bionic Engineering Conference to be held from 18-20 September, 2011

The International Bionic Engineering Conference 2011 organised by Elsevier, the leading publisher of scientific, technical and medical information products and services, aims to bridge the gap between academic research and industrial development in a field that is rapidly growing and gaining recognition across many disciplines.

16 Dec 2010

Precision BioSciences receive $3 million to develop DNE technology

Precision BioSciences, today announced that it has been awarded over $3 million across four government grants. These grants were each awarded to Precision during the 4th Quarter of 2010 and came from the National Institute of Standards and Technology, the Treasury Department, the National Institute of Health, and the State of North Carolina.

16 Dec 2010

Study finds that immobilization devices significantly reduce braking response time

Patients recovering from a right foot injury or surgery should think twice about how soon they want to begin driving again. According to a new study from the Journal of Bone and Joint Surgery (JBJS), it takes much longer to brake when the driver is wearing an immobilization device - like a splint or brace, than it does when wearing normal footwear.

16 Dec 2010

Pico-Tesla commences pilot study of Magneceutical Therapy in fibromyalgia patients

Pico-Tesla, The Magneceutical® Company, announced that it has commenced a randomized, double-blind, placebo-controlled pilot study of 30 patients who have fibromyalgia. The pilot study seeks to determine whether the application of magnetic fields generated by Pico-Tesla's patented Resonator™ system can be effective as an adjunctive therapy to oral medications in ameliorating the symptoms of fibromyalgia.

16 Dec 2010

Envoy's successfull application of bacTRAP technology triggers milestone payment from Merck

Envoy Therapeutics, a drug discovery company, today announced that it has reached a milestone in its strategic alliance with Merck.

16 Dec 2010

New visualisation software tool for older people to understand mobility problems

Mobility challenges facing older people can now be better understood by clinicians, healthcare practitioners and design professionals, thanks to a new innovative software tool.

16 Dec 2010

BioAlliance wins grant and award for new applications of mucoadhesive Lauriad technology

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, announces the award of a grant from the ANR (the French state Research National Agency) and a label award from both "Clusters of excellence", Medicen Paris Region and Atlanpole, for two new applications of its mucoadhesive Lauriad™ technology. These projects are dedicated to the development of new biological products based on the Lauriad™ technology allowing mucous penetration of a biologically active compound.

16 Dec 2010

IDS recieves grant for two CLTM systems

Imaging Diagnostic Systems, Inc., a pioneer in laser breast imaging, announced today that it has received deposits for two CTLM systems from its distributor Mukesh Jain of Jainsons Pty Ltd for India and Indonesia.

16 Dec 2010

DeCODE Genetics identify SNPs to derive PSA threshold for diagnosing prostrate cancer

Scientists from deCODE genetics and academic colleagues from Iceland, the UK, US, Netherlands, Spain and Romania today report the discovery of a set of single-letter variations in the sequence of the human genome that impact individual baseline levels of prostate specific antigen, or PSA.

16 Dec 2010

SBUMC to unveil one-of-a-kind neuroendovascular simulator

Stony Brook University Medical Center will unveil this Friday a one-of-a-kind neuroendovascular simulator that recreates vasculature in the brain, including scenarios of damaged vessels from acute stroke, brain aneurysms, and other cerebrovascular anomalies. Affectionately known in the lab as "Headley".

16 Dec 2010

Epitomics enters contract with SAIC Frederick to develop rabbit monoclonal antibodies for CPTC program

Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).

16 Dec 2010

Study demonstrates BRACAnalysis testing for women with breast carcinoma in situ

Myriad Genetics, announced today that an article entitled "Prevalence of BRCA1 and BRCA2 Mutations In Women With Carcinoma In Situ of the Breast Referred for Genetic Testing" will appear in the December 2010 issue of the journal Cancer Prevention Research.

16 Dec 2010

BioPontis Alliance, Merck enter innovative strategic agreement in translational drug research

BioPontis Alliance, LLC announced today that it has entered into an innovative strategic agreement with Merck (known outside the US and Canada as MSD) designed to bridge the gap between early academic discovery science and the development of medicines and technologies that impact human health. The announcement was made this week at the prestigious Partnering For Cures Conference that is convened annually for the purpose of forging strategic cross-sector collaborations.

16 Dec 2010

PEG-Prom encased nanoparticle aids in cancer detection and treatment

In a proof of principal study in mice, scientists at Johns Hopkins and the Virginia Commonwealth University have shown that a set of genetic instructions encased in a nanoparticle can be used as an "ignition switch" to rev up gene activity that aids cancer detection and treatment.

16 Dec 2010

Ultrasound-based diagnosis for rapid detection of benign and malignant ovarian cancer

It is crucial to differentiate between benign and malignant ovarian cysts and tumours in a fast and reliable manner. This improves the surgical management and prognosis of the patient.

16 Dec 2010

FDA grants marketing clearance to Accuray's CyberKnife VSI System Lung Optimized Treatment

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market Lung Optimized Treatment, a new component of the CyberKnife® VSI™ System. The 510(k) clearance enables Accuray to provide physicians with greater flexibility in delivering radiosurgery treatments to patients with lung cancer, the most common and deadly cancer worldwide.

15 Dec 2010

MCSA Tool for colonoscopy trainees to assess cognitive and motor skills

Researchers at the Mayo Clinic in Rochester, have developed a new skills assessment tool for colonoscopy trainees.

15 Dec 2010

AmoyDx receives SFDA approval for its EGFR and BRAF mutations detection kits

Amoy Diagnostics announced today that its EGFR and BRAF mutation detection kits received market approval from China's State Food and Drug Administration (SFDA). The SFDA is the competent authority for regulating drugs and in vitro diagnostics in mainland China. The approval allows AmoyDx to market the EGFR and BRAF tests for clinical use in China.

15 Dec 2010

Device / Technology News

MedicAlert Foundation's 'Code of Conduct' helps evaluate integrity of emergency medical information

Miracor granted CE-Mark for PICSO Impulse System to improve ACS revascularization following PCI

International Bionic Engineering Conference to be held from 18-20 September, 2011

Precision BioSciences receive $3 million to develop DNE technology

Study finds that immobilization devices significantly reduce braking response time

Pico-Tesla commences pilot study of Magneceutical Therapy in fibromyalgia patients

Envoy's successfull application of bacTRAP technology triggers milestone payment from Merck

New visualisation software tool for older people to understand mobility problems

BioAlliance wins grant and award for new applications of mucoadhesive Lauriad technology

IDS recieves grant for two CLTM systems

DeCODE Genetics identify SNPs to derive PSA threshold for diagnosing prostrate cancer

SBUMC to unveil one-of-a-kind neuroendovascular simulator

Epitomics enters contract with SAIC Frederick to develop rabbit monoclonal antibodies for CPTC program

Study demonstrates BRACAnalysis testing for women with breast carcinoma in situ

BioPontis Alliance, Merck enter innovative strategic agreement in translational drug research

PEG-Prom encased nanoparticle aids in cancer detection and treatment

Ultrasound-based diagnosis for rapid detection of benign and malignant ovarian cancer

FDA grants marketing clearance to Accuray's CyberKnife VSI System Lung Optimized Treatment

MCSA Tool for colonoscopy trainees to assess cognitive and motor skills

AmoyDx receives SFDA approval for its EGFR and BRAF mutations detection kits

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Latest News